MoneyWorks4Me

Guj. Themis Biosyn - Quaterly Results

11 Feb 2022 Evaluate
Net sales declined -23.77%  to  Rs. 186.04 million from Rs. 244.04 millions.Net profit declined -4.67% to Rs. 71.21 millions from Rs. 74.70 millions.A decline of 104.89 millions was observed in the OP in the quarter ended December 2021 from 113.50 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 186.04 244.04 -23.77 860.91 672.65 27.99 905.63 851.24 6.39
Other Income 6.93 6.60 5.00 25.41 24.71 2.83 32.67 17.04 91.73
PBIDT 104.89 113.50 -7.59 475.06 344.95 37.72 435.95 335.42 29.97
Interest 3.27 1.71 91.23 6.49 6.89 -5.81 9.81 9.23 6.28
PBDT 101.62 111.79 -9.10 468.57 338.06 38.61 426.14 326.19 30.64
Depreciation 5.71 3.81 49.87 16.89 10.61 59.19 17.33 13.62 27.24
PBT 95.91 107.98 -11.18 451.68 327.45 37.94 408.81 312.57 30.79
TAX 24.70 33.28 -25.78 113.33 83.58 35.59 107.02 75.82 41.15
Deferred Tax 0.34 0.28 21.43 0.10 0.58 -82.76 1.26 -0.54 -333.33
PAT 71.21 74.70 -4.67 338.35 243.87 38.74 301.79 236.75 27.47
Equity 72.64 72.64 0.00 72.64 72.64 0.00 72.64 72.64 0.00
PBIDTM(%) 56.38 46.51 21.23 55.18 51.28 7.60 48.14 39.40 22.17
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..